Hypophosphatemia
📧 Sign up to get email alerts when something new happens for Hypophosphatemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-12FDA Approved: POTASSIUM PHOSPHATES — Original Application (Caplin Steriles Limited)
FDA approved Caplin Steriles Limited's Original Abbreviated New Drug Application for Potassium Phosphates (potassium phosphate salts), autho…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Protocolised Management of Phosphate Replacement Trial [NA]
Clinical trial protocol update for protocolised management of phosphate replacement; the study involves phosphate deficiency/hypophosphatemi…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia. [NA]
The document reports a clinical trial evaluating enteral supplementation with sodium dihydrogen phosphate and disodium hydrogen phosphate gr…
-
FDA approval · 2025-09-11FDA Approved: POTASSIUM PHOSPHATES — Original Application (Hospira, Inc.)
FDA approved Hospira's Potassium Phosphates as an original generic product (ANDA 217459). It is indicated to treat phosphate deficiency (hyp…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in The Treatment of Hypophosphatemia in ICU Patients [Phase 2, Phase 3]
The trial update reports on Phase 2 and Phase 3 results comparing a diluted oral phosphate enema with intravenous sodium glycerophosphate fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-05-23Clinical Trial Update: The Impact of Phosphate Metabolism on Healthy Aging [EARLY_Phase 1]
A Yale University–sponsored early-phase clinical trial investigating phosphate metabolism in healthy aging is currently suspended; the trial…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding Syndrome
This completed clinical trial update reports metabolic pathway analysis in ICU patients with refeeding syndrome.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Validation of the GIDS and Description of Phosphate Disorders
A completed clinical trial focusing on validating the GIDS and describing phosphate disorders, including hypophosphatemia.
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism
This clinical trials entry describes the plan to establish an Italian multicenter database for patients with phosphate metabolism disorders,…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients [Phase 2]
This clinical trial update describes a Phase 2 study evaluating dipyridamole to prevent post-transplant hypophosphatemia in kidney transplan…
-
FDA approval · 2025-01-24FDA Approved: POTASSIUM PHOSPHATES — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s Original Application for Potassium Phosphates, enabling a generic version of the product. It supports use …
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: IV Iron-induced Hypophosphatemia After RYGB [Phase 4]
Phase 4 clinical trial update on IV iron-induced hypophosphatemia after Roux-en-Y gastric bypass, currently recruiting.
-
FDA approval · 2024-07-11FDA Approved: POTASSIUM PHOSPHATE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for a generic potassium phosphate product (Potassium Phosphate) manufactured by Somerset Therapeut…
-
FDA approval · 2023-10-10FDA Approved: POTASSIUM PHOSPHATES — Original Application (Amneal Pharmaceuticals Private Limited)
FDA approved Amneal’s Potassium Phosphates injection as an Original Application, granting regulatory clearance for the generic potassium pho…
-
FDA approval · 2023-10-02FDA Approved: POTASSIUM PHOSPHATES — Original Application (American Regent, Inc.)
FDA approved an original-application (ANDA) for Potassium Phosphates from American Regent, Inc., adding a generic potassium phosphate produc…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU [Phase 4]
A Phase 4 clinical trial evaluating whether hypophosphatemia affects outcomes in septic patients in the ICU is ongoing; current status is un…
-
FDA approval · 2019-11-26FDA Approved: POTASSIUM PHOSPHATES — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for Potassium Phosphates, a parenteral electrolyte product used to address phosp…
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
An observational clinical trial from National Taiwan University Hospital tracks changes in fibroblast growth factor 23 (FGF23) levels in pat…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: FGF-23 Suppressibility by Calcitonin [NA]
A completed clinical trial investigated whether calcitonin can suppress FGF-23 in patients with hypophosphatemia.
-
CLINICAL_TRIALS research · 2012-08-31Clinical Trial Update: Investigating a New Way of Giving Medicine to Newborn and Preterm Babies [Phase 2]
A Phase 2 clinical trial update describes a new method of administering medicine to newborn and preterm babies, focusing on hypophosphatemia…